The 18,000 clinical trials published each year aren't doing much to improve human health, argues Peter Pronovost. Health delivery research can, by improving delivery and impact of already-proven interventions. But doing so will require cutting a slice of the funding pie for social scientists and other untouchables in the "omics"-loving academic caste system. JAMA 2011;306:310-311.